ThinkCyte Awarded NEDO PCA Grant to Advance Label-free Cell Sorting Technology for Cell Therapy

Tokyo, Japan | August 24, 2020

ThinkCyte, a company focusing on the development of novel cell therapy, drug screening, and clinical diagnostic platforms, has been awarded a Product Commercialization Alliance (PCA) grant from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The grant will provide up to JPY250 million (approx. US$2.4 million) to advance research and development work on the company’s high-content label-free cell sorting system for cell therapy. To learn more about the grant program by NEDO, please visit NEDO’s website at